What the study found
The study reports that DNA damage burden causes selective loss of CUX2 neurons in neuroinflammation. It also states that L2/3ENs contribute to selective vulnerability in neuroinflammatory injury.
Why the authors say this matters
The abstract does not provide an explicit explanation of why the findings matter beyond stating the reported selective vulnerability in neuroinflammatory injury.
What the researchers tested
This is identified as a research article, but the abstract provided here does not describe the study design, samples, or methods.
What worked and what didn't
The abstract states that DNA damage burden was associated with selective CUX2 neuron loss, and that L2/3ENs contribute to selective vulnerability in neuroinflammatory injury. No additional results, comparisons, or negative findings are described in the available text.
What to keep in mind
The available abstract is very brief and does not describe limitations, experimental details, or the scope of the findings beyond the stated association and selective vulnerability.
Key points
- DNA damage burden is reported to cause selective loss of CUX2 neurons in neuroinflammation.
- L2/3ENs are said to contribute to selective vulnerability in neuroinflammatory injury.
- The provided abstract does not describe the study methods or experimental design.
- No limitations or caveats are stated in the available abstract text.
Disclosure
- Research title:
- DNA damage burden causes selective CUX2 neuron loss in neuroinflammation
- Authors:
- Laura Morcom, Wenlong Xia, Zhaoyang Xu, Yashika Awasthi, Celine Geywitz, Matthew O. Ellis, Tomas Noli, Amel Zulji, Daniel Yamamoto, Gemma C. Girdler, Li Kai, Keying Zhu, Mingming Wei, Xiao-Yan Tang, Kimberly K. Hoi, Julio Gonzalez-Maya, Greg J. Duncan, Adrien Vaquié, Diana Gold Diaz, Riki Kawaguchi, Erdong Liu, Yu Sun, Denny Yang, Gregory D. Jordan, I-Ling Lu, Staffan Holmqvist, Theresa Bartels, Katherine Ridley, Jennifer Ja-Yoon Choi, Santos Franco, Eric J. Huang, Ben Emery, Daniel Geschwind, Lucas Schirmer, Gabriel Balmus, Brian Popko, Stephen P.J. Fancy, David H. Rowitch
- Institutions:
- Wellcome/MRC Cambridge Stem Cell Institute, University of Cambridge, UK Dementia Research Institute, University of California, San Francisco, Cedars-Sinai Medical Center, Northwestern University, Heidelberg University, University Hospital Heidelberg, University Medical Centre Mannheim, Oregon Health & Science University, Center for Neurosciences, University of California, Los Angeles, Broad Center, University of Colorado Anschutz Medical Campus, Center for Autism and Related Disorders, Bernstein Center for Computational Neuroscience Heidelberg-Mannheim, Romanian Institute of Science and Technology
- Publication date:
- 2026-04-01
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.


